While adjusting BMI, FPG, albumin, SBP, DBP, ALT, AST, BUN, Cr, uric acid and direct bilirubin, the hazard ratio (HR) for non-obese NAFLD patients was gradually enhanced across the quartiles of TG/HDL-C ratio. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.